UpdatesPress Release
Aarti Pharmalabs inaugurated a new manufacturing block at Tarapur, adding 3600 TPA to Xanthine derivatives capacity, now totaling 9600 TPA.
Aarti Pharmalabs LimitedAARTIPHARM · Filed with the exchange
This positions them among the top 3 global manufacturers.
Trial production has begun, with full utilization expected in coming quarters.
No comments yet. Be the first.